Author: Brouqui, P.; Giraud-Gatineau, A.; Raoult, D.
Title: Remdesivir investigational trials in COVID-19: a critical reappraisal Cord-id: pkklt77i Document date: 2020_6_7
ID: pkklt77i
Snippet: Abstract During outbreak of emerging disease, the most important aim is to discover an effective drug to save life. Consequently, a lot of effort are generally made by the industry to promote clinical trials with new drugs. Here we review evidence of the 8 most recent reports including 3 randomized controlled trials on the clinical efficacy of remdesivir in treating COVID-19 patient. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention.
Document: Abstract During outbreak of emerging disease, the most important aim is to discover an effective drug to save life. Consequently, a lot of effort are generally made by the industry to promote clinical trials with new drugs. Here we review evidence of the 8 most recent reports including 3 randomized controlled trials on the clinical efficacy of remdesivir in treating COVID-19 patient. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention.
Search related documents:
Co phrase search for related documents- acute lung and low flow oxygen: 1
Co phrase search for related documents, hyperlinks ordered by date